Dr. Thomas W. Flaig, MD

Dr. Flaig practices at UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth.

Dr. Flaig's NPI, 1881620326, was assigned on June 25, 2006. Dr. Flaig graduated from University Of Minnesota Medical School in 1999. Dr. Flaig holds Colorado license 44457.

Dr. Flaig's primary practice is UCHealth University of Colorado Hospital, at 12605 E 16th Ave, Aurora, CO 80045 in Adams County. The practice phone is (720) 848-0000.

Dr. Flaig's primary practice is UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth. Dr. Flaig is also affiliated with UCHealth Medical Center of the Rockies. The medical group on file is University of Colorado Medicine (CU Medicine). Dmand AI also links Dr. Flaig to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Flaig practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Flaig's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Flaig is board certified in medical oncology by the American Board of Internal Medicine. Dr. Flaig is licensed in Colorado.

Dmand AI lists chronic anemia and prostate cancer among the conditions Dr. Flaig treats.

CMS data shows 313 Medicare services from Dr. Flaig across 4 procedure codes in 2024, for 86 Medicare patients. Medicare paid $21,149 for them.

CMS counts 86 Medicare patients who saw Dr. Flaig in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have cancer, and 71% have high cholesterol. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Flaig's median patient age at 76, with 6% women.

In 2024, Dr. Flaig wrote 219 Medicare Part D claims for 30 patients. 69% of them were for generic drugs. CMS names the drug for 162 of them, across 4 drugs with 11 or more claims each, at $790,393 in total drug cost. In 2023, CMS named 58 claims across 2 drugs.

Dr. Flaig accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Flaig as offering telehealth.

Dmand AI links 162 papers to Dr. Flaig, published from 2006 to 2025. 2021 was the busiest year, with 13. The most frequent topics are Prostatic Neoplasms, Urinary Bladder Neoplasms and Antineoplastic Agents. Dr. Flaig has published most often in Oncology (Williston Park). Dr. Flaig's most frequent co-authors are Elizabeth Riley Kessler, MD, Elaine T. Lam, MD and Elward David Crawford, MD.

Dmand AI links Dr. Flaig to 9 clinical trials, 4 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Urethral Neoplasms, Urinary Bladder Neoplasms and Ureteral Neoplasms. University of Colorado, Denver sponsors the most, 3. Open Payments lists research payments to Dr. Flaig that name 3 trials.

CMS Open Payments shows 21 general payments to Dr. Flaig from 4 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 47% of the total. Genentech, Inc. paid the most, $1,887. It also lists 32 research payments totaling $18,093 from 2018 to 2025, naming 3 clinical trials.

Dmand AI lists 1 award for Dr. Flaig, most recently CMS Stage 1 EHR in 2013.

Dr. Flaig graduated from University Of Minnesota Medical School in 1999.

Dr. Flaig is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.